HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A newly discovered metabolic diseases due to defects in the pentose pathway].

Abstract
Two previously unreported inborn errors of metabolism occur in the reversible part of the pentose phosphate pathway. Deficiency of ribose-5-phosphate isomerase has been described in one patient who suffered from a progressive leukoencephalopathy and developmental delay. Transaldolase deficiency has been diagnosed in 11 patients from 6 families in which the probands presented in the newborn and antenatal period with hepatospIenomegaly, hemolytic anaemia, hepatic fibrosis, kidney problems. Enzymes deficiency results in accumulations in body fluids erythritol, arabitol, ribitol, sedoheptitol, sedoheptulose, sedoheptulose-7-phosphate. Isomerase and transaldolase activity can be determined in leukocytes or fibroblasts.
AuthorsAnna Tylki-Szymańska, Teresa J Stradomska
JournalPostepy biochemii (Postepy Biochem) Vol. 57 Issue 2 Pg. 168-71 ( 2011) ISSN: 0032-5422 [Print] Poland
Vernacular TitleNowo opisane choroby metaboliczne zwiazane z błedami metabolizmu na szlaku przemiany pentoz.
PMID21913417 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Isomerases
  • Aldose-Ketose Isomerases
  • ribosephosphate isomerase
Topics
  • Aldose-Ketose Isomerases (deficiency)
  • Humans
  • Isomerases (deficiency)
  • Metabolism, Inborn Errors (diagnosis, metabolism)
  • Pentose Phosphate Pathway

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: